Market Closed -
Japan Exchange
01:57:00 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
806
JPY
|
+0.37%
|
|
-0.12%
|
+1.26%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,241
|
2,257
|
1,658
|
3,205
|
2,526
|
2,917
|
Enterprise Value (EV)
1 |
4,030
|
2,035
|
1,239
|
2,589
|
1,821
|
1,869
|
P/E ratio
|
35.9
x
|
24
x
|
6.85
x
|
16.9
x
|
13.2
x
|
9.03
x
|
Yield
|
0.6%
|
1.13%
|
1.6%
|
1.01%
|
1.5%
|
1.82%
|
Capitalization / Revenue
|
0.49
x
|
0.25
x
|
0.18
x
|
0.37
x
|
0.28
x
|
0.32
x
|
EV / Revenue
|
0.47
x
|
0.23
x
|
0.14
x
|
0.3
x
|
0.2
x
|
0.2
x
|
EV / EBITDA
|
11.5
x
|
5.81
x
|
5.06
x
|
5.91
x
|
4.01
x
|
3.19
x
|
EV / FCF
|
11.7
x
|
10.4
x
|
12.9
x
|
9.63
x
|
12.7
x
|
5.76
x
|
FCF Yield
|
8.55%
|
9.61%
|
7.77%
|
10.4%
|
7.85%
|
17.4%
|
Price to Book
|
3.01
x
|
1.53
x
|
0.98
x
|
1.73
x
|
1.25
x
|
1.26
x
|
Nbr of stocks (in thousands)
|
3,793
|
3,793
|
3,793
|
3,793
|
3,793
|
3,793
|
Reference price
2 |
1,118
|
595.0
|
437.0
|
845.0
|
666.0
|
769.0
|
Announcement Date
|
6/27/18
|
6/26/19
|
6/24/20
|
6/25/21
|
6/27/22
|
6/29/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
8,611
|
8,906
|
9,055
|
8,686
|
8,965
|
9,237
|
EBITDA
1 |
351
|
350
|
245
|
438
|
454
|
586
|
EBIT
1 |
235
|
226
|
123
|
305
|
306
|
431
|
Operating Margin
|
2.73%
|
2.54%
|
1.36%
|
3.51%
|
3.41%
|
4.67%
|
Earnings before Tax (EBT)
1 |
219
|
170
|
323
|
331
|
326
|
503
|
Net income
1 |
118
|
94
|
242
|
190
|
192
|
323
|
Net margin
|
1.37%
|
1.06%
|
2.67%
|
2.19%
|
2.14%
|
3.5%
|
EPS
2 |
31.11
|
24.78
|
63.80
|
50.09
|
50.62
|
85.15
|
Free Cash Flow
1 |
344.6
|
195.6
|
96.25
|
268.8
|
143
|
324.5
|
FCF margin
|
4%
|
2.2%
|
1.06%
|
3.09%
|
1.6%
|
3.51%
|
FCF Conversion (EBITDA)
|
98.18%
|
55.89%
|
39.29%
|
61.36%
|
31.5%
|
55.38%
|
FCF Conversion (Net income)
|
292.06%
|
208.11%
|
39.77%
|
141.45%
|
74.48%
|
100.46%
|
Dividend per Share
2 |
6.750
|
6.750
|
7.000
|
8.500
|
10.00
|
14.00
|
Announcement Date
|
6/27/18
|
6/26/19
|
6/24/20
|
6/25/21
|
6/27/22
|
6/29/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
211
|
222
|
419
|
616
|
705
|
1,048
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
345
|
196
|
96.3
|
269
|
143
|
325
|
ROE (net income / shareholders' equity)
|
7.86%
|
6.25%
|
15.2%
|
10.7%
|
9.91%
|
14.9%
|
ROA (Net income/ Total Assets)
|
5.08%
|
4.65%
|
2.43%
|
5.93%
|
5.92%
|
7.98%
|
Assets
1 |
2,323
|
2,023
|
9,949
|
3,206
|
3,242
|
4,046
|
Book Value Per Share
2 |
372.0
|
390.0
|
447.0
|
490.0
|
532.0
|
611.0
|
Cash Flow per Share
2 |
194.0
|
202.0
|
252.0
|
255.0
|
245.0
|
316.0
|
Capex
1 |
31
|
56
|
17
|
29
|
163
|
38
|
Capex / Sales
|
0.36%
|
0.63%
|
0.19%
|
0.33%
|
1.82%
|
0.41%
|
Announcement Date
|
6/27/18
|
6/26/19
|
6/24/20
|
6/25/21
|
6/27/22
|
6/29/23
|
|
1st Jan change
|
Capi.
|
---|
| +1.26% | 19.88M | | -2.77% | 3.02B | | 0.00% | 1.89B | | +5.97% | 1.59B | | +52.30% | 637M | | -3.48% | 501M | | -37.21% | 358M | | -11.94% | 141M | | +1.92% | 70.36M |
Home Healthcare Services
|